HMG-CoA Reductase Inhibitors: is the Endothelium the Primary Target?

· 4 min read
HMG-CoA Reductase Inhibitors: is the Endothelium the Primary Target?
Friendly Mule Free Stock Photo - Public Domain Pictures

Laumann EO, Paik A, Rosen RC . Barada J . Successful salvage of sildenafil (Viagra) failures: benefits of patient schooling and rechallenge with sildenafil. Safarinejad MR . Prevalence and risk elements for erectile dysfunction in a population-based research in Iran.  cipla sildenafil  . Challenges in oral therapy for erectile dysfunction. Efficacy, security and affected person acceptance of sildenafil citrate as therapy for erectile dysfunction. Jiann BP, Yu CC, Su CC, Huang JK . McMahon CG, Samali R, Johnson H . Sexual dysfunction in the United States: prevalence and predictors. Int J Impot Res 2000; 12 (Suppl 4): S6-11. Vardenafil rescue rates of sildenafil nonresponders: objective evaluation of 327 patients with erectile dysfunction. McKinlay JB . The worldwide prevalence and epidemiology of erectile dysfunction. Aytaç IA, McKinlay JB, Krane RJ . Int J Impot Res 2001; 13 (Suppl 4): S49. The likely worldwide enhance in erectile dysfunction between 1995 and 2025 and some doable policy penalties. Brisson TE, Broderick GA, Thiel DD, Heckman MG, Pinkstaff DM .

Red and Black Abstract Ink Background

Effects of statin therapy on serum sex steroids levels and autonomic and erectile operate. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. McFarlane SI, Muniyappa R, Francisco R, Sowers JR . Impaired brachial artery endothelium-dependent and -unbiased vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. A retrospective research of the connection between biomarkers of atherosclerosis and erectile dysfunction in 988 men. Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E et al. Eaton CB, Liu YL, Mittleman MA, Miner M, Glasser DB, Rimm EB . Surveillance of cardiovascular risk elements for outpatients in different erectile dysfunction severity. Schouten BW, Bohnen AM, Bosch JL, Bernsen RM, Deckers JW, Dohle GR et al. Chang ST, Chu CM, Hsu JT, Lin Pc, Shee JJ . Erectile dysfunction prospectively related to cardiovascular illness in the Dutch basic inhabitants: outcomes from the Krimpen Study. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ .

Clinical assessment 145: Pleiotropic effects of statins: lipid reduction and past. Hong SK, Han BK, Jeong SJ, Byun SS, Lee SE . Improvement in erectile perform in men with natural erectile dysfunction by correction of elevated cholesterol ranges: a clinical statement. Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E et al. Herrmann HC, Levine LA, Macaluso Jr J, Walsh M, Bradbury D, Schwartz S et al. Saltzman EA, Guay AT, Jacobson J . Atorvastatin enhances sildenafil-induced vasodilation by nitric oxide-mediated mechanisms. Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE . Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. NIH Consensus Development Panel on Impotence. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially conscious of sildenafil? NIH Consensus Conference. Impotence. Hypothesis and pilot trial outcomes.

Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . HMG CoA reductase inhibitors and impotence: two case collection from the Spanish and French drug monitoring programs. Heart rate evaluation in regular topics of various age group. Acharya UR, Kannathal N, Sing OW, Ping LY, Chua T . Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . HMG-CoA reductase inhibitors: is the endothelium the primary target? Carvajal A, Macias D, Sáinz M, Ortega S, Martín Arias LH, Velasco A et al. Puddu P, Puddu GM, Muscari A . The effects of quinapril and atorvastatin on the responsiveness to sildenafil in males with erectile dysfunction. Boyd IW . Comment: HMG-CoA reductase inhibitor-induced impotence. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J et al. Bank AJ, Kelly AS, Kaiser DR, Crawford WW, Waxman B, Schow DA et al. Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S . Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . The international index of erectile perform (IIEF): a multidimensional scale for evaluation of erectile operate. Antioxidant effects of statins through S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective perform of statins. Erectile dysfunction and statin treatment in high cardiovascular threat patients. Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ et al. Jackson G . Simvastatin and impotence. Impotence and its medical and psychosocial correlates: outcomes of the Massachusetts Male Aging Study. Development and analysis of an abridged, 5-merchandise model of the International Index of Erectile Function (IIEF-5) as a diagnostic device for erectile dysfunction. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Rechallenge prior sildenafil nonresponders. Safarinejad MR, Kolahi AA, Ghaedi G . Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with fight-associated submit-traumatic stress disorder: a double-blind, randomized and placebo-managed research. Sildenafil for treatment of erectile dysfunction in men with diabetes. Guay AT, Perez JB, Jacobson J, Newton RA . Safarinejad MR . Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in males with a number of sclerosis: a double-blind, placebo managed, randomized study. Rendell MS, Rajfer J, Wicker PA, Smith MD . Safarinejad MR . Oral sildenafil within the therapy of erectile dysfunction in diabetic men: a randomized double-blind and placebo-managed study. Doğru MT, Başar MM, Simşek A, Yuvanç E, Güneri M, Ebinç H et al. Safarinejad MR . Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-managed research. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. Safarinejad MR, Hosseini SY . Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a inhabitants with associated organic threat factors.